SY19 - "Hot and Flashy" Topics in Menopause

Saturday, June 13, 2026

4:30 PM - 6:00 PM CT

Location: Room W375A

Symposium Chair(s)

Gina Woods, MD

Professor
Department of Medicine
University of California, San Diego
La Jolla, CA, United States

Disclosure(s): Bayer Inc.: Advisory Board (); Roon: Consultant (); Solarea, Bio: Consultant ()
LT

Laila Tabatabai, MD, CCD

Bone Health Initiative
Weill Cornell Medical College
Houston, Texas, United States

Disclosure information not submitted.

Disclosure(s):

Gina Woods, MD: Bayer Inc.: Advisory Board (); Roon: Consultant (); Solarea, Bio: Consultant ()

Discover the latest evidence shaping midlife women's health in this dynamic session featuring world-renowned experts. With new data highlighting the safety of hormone therapy and a resurgence of interest in its role, we'll explore how to strike the right balance in clinical practice. The program also covers strategies to preserve bone health during the menopausal transition and reviews effective non-hormonal options for vasomotor symptoms. Attendees will leave with practical, evidence-based insights to optimize care for diverse patient needs.

Presentations:

4:30 PM - 5:00 PM CT

Non-Hormonal Treatments for Vasomotor Symptoms
Symposium Speaker: JoAnn V. Pinkerton, MD – University of Virginia
5:00 PM - 5:30 PM CT

Striking the Balance: Renewed Focus on HRT Hormonal Therapy
Symposium Speaker: James A. Simon, MD – The George Washington University School of Medicine
5:30 PM - 6:00 PM CT

Preserving Bone During the Menopausal Transition
Symposium Speaker: E Lewiecki, MD (he/him/his) – NEW MEXICO CLINICAL RESEARCH & OSTEOPOROSIS CENTER